INTERNATIONAL STEM CELL CORPORATION (ISCO) Operating margin 2016–2025
INTERNATIONAL STEM CELL CORPORATION (ISCO) operating margin by fiscal year — reported operating income divided by reported revenue.
-2.9%FY2025 · since FY2016: -67.7% → -2.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.9% | -2.2 pp |
| FY2024 | -0.7% | +7.8 pp |
| FY2023 | -8.5% | -6.3 pp |
| FY2022 | -2.2% | +24.5 pp |
| FY2021 | -26.8% | +12.8 pp |
| FY2020 | -39.5% | +20.9 pp |
| FY2019 | -60.5% | -29.1 pp |
| FY2018 | -31.3% | +35.0 pp |
| FY2017 | -66.3% | +1.4 pp |
| FY2016 | -67.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice